Leukemia Research
Volume 25, Issue 9 , Pages 813-820 , 1 September 2001

Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells

  • Yuki Ishii

      Affiliations

    • Department of Chemotherapy, Saitama Cancer Center, Research Institute, 818 Komuro, Ina, Saitama 362-0806, Japan
    • Institute of Biological Sciences, University of Tsukuba, Ibaraki 305-8572, Japan
    • ,
  • Shingo Sakai

      Affiliations

    • Institute of Biological Sciences, University of Tsukuba, Ibaraki 305-8572, Japan
    • ,
  • Yoshio Honma

      Affiliations

    • Department of Chemotherapy, Saitama Cancer Center, Research Institute, 818 Komuro, Ina, Saitama 362-0806, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-48-7221111; fax: +81-480-854630

Received 19 September 2000 ,Accepted 20 January 2001.

References 

  1. Honma Y, Okabe-Kado J, Hozumi M, Uehara Y, Mizuno S. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity. Cancer Res. 1989;49:331
  2. Makishima M, Honma Y, Hozumi M, Sampi K, Hattori M, Motoyoshi K. Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase. FEBS Lett. 1991;287:175
  3. Makishima M, Honma Y, Hozumi M, Sampi K, Hattori M, Umezawa K, et al. Effects of inhibitors of tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells. Leuk. Res. 1991;15:701
  4. Okazaki T, Kato Y, Mochizuki T, Tashima M, Sawada H, Uchino H. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds. Exp. Hematol. 1988;16:42
  5. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 1998;58:3163
  6. Kharbanda S, Saleen A, Emoto Y, Stone R, Rapp U, Kufe D. Activation of raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 1994;269:872
  7. Marchisio M, Bertagnolo V, Colamussi ML, Capitani S, Neri LM. Phosphatidylinositol 3-kinase in HL-60 nuclei is bound to the nuclear matrix and increases during granulocytic differentiation. Biochem. Biophys. Res. Commun. 1998;253:346
  8. Baier R, Bondeva T, Klinger R, Bondev A, Wetzkwe R. Retinoic acid induces selective expression of phosphoinositide-3-kinase γ in myelomonocytic U937 cells. Cell Growth Differ. 1999;10:447
  9. Simpson RU, O'Connekk TD, Pan Q, Newhouse J, Somerman MJ. Antisense oligonucleotides targeted against protein kinase Cß and CβII block 1,25-(OH)2D3-induced differentiation. J. Biol. Chem. 1998;273:19587
  10. Kaneki M, Kharbanda S, Pandey P, Yoshida K, Takenawa M, Liou J, et al. Functional role for protein kinase Cß as a regulator of stress-activated protein kinase activation and monocytic differentiation of myeloid leukemia cells. Mol. Cell Biol. 1999;19:461
  11. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977;270:347
  12. Kishi K, Toba K, Azegami T, Tsukada N, Uesugi Y, Masuko M, et al. Hematopoietic cytokine dependent differentiation to eosinophils and neutrophils in newly established acute promyelocytic leukemia cell line with t (15; 17). Exp. Hematol. 1998;26:135
  13. Minowada J. Immunology of leukemic cells. In:  Grunz F,  Henderson E editor. Leukemia. New York: Grune and Stratton; 1982;p. 119
  14. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer. 1980;26:171
  15. Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line. Int. J. Cancer. 1976;17:565
  16. Makishima M, Kanatani Y, Yamamoto-Yamaguchi Y, Honma Y. Enhancement of activity of 1α,25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an α-tocopherol ester of all-trans retinoic acid. Blood. 1996;87:3384
  17. Makishima M, Honma Y, Hozumi M, Sampi K, Hattori M, Ishikawa I, et al. Induction of differentiation of human myeloid leukemia HL-60 cells by novel pyrimidine nucleoside analogs. Biochim. Biophys. Acta. 1991;1094:1
  18. Honma Y, Yamamoto-Yamaguchi Y, Kanatani Y. Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an antitumour effect on human non-small cell lung carcinoma cells grown in nude mice. Br. J. Cancer. 1999;80:96
  19. Honma Y, Takenaga K, Kasukabe T, Hozumi H. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem. Biophys. Res. Commun. 1980;95:507
  20. Kagechika H, Kawachi E, Furusawa H, Saito G, Iwanami N, Umemiya H, et al. Inhibition of IL-1-induced IL-6 production by synthetic retinoids. Biochem. Biophys. Res. Commun. 1997;231:243
  21. Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, et al. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 1997;4:311
  22. Lisnock J, Tebben A, Frantz B, O'Neill EA, Croft G, O'Keefe SJ, et al. Molecular basis for p38 protein kinase inhibitor specificity. Biochemistry. 1998;37:16573
  23. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. p38 mitogen- activated protein kinase inhibitors-Mechanisms and therapeutic potentials. Pharmacol. Ther. 1999;82:389
  24. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, et al. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS Lett. 1995;364:229
  25. Wang X, Rao J, Studzinski GP. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D3-induced differentiation of human leukemia HL60 cells. Exp. Cell Res. 2000;258:425
  26. Hall-Jackson CA, Goedert M, Hedge P, Cohen P. Effect of SB203580 on the activity of c-Raf in vitro and in vivo. Oncogene. 1999;18:2047
  27. Birkenkamp KU, Tuyt LML, Lummen C, Wierenga ATJ, Kruijer W, Vellenga E. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br. J. Pharmacol. 2000;131:99
  28. Niitsu N, Umeda M, Honma Y. Induction of differentiation of human myeloid leukemia cells by 2′-deoxycoformycin in combination with 2′-deoxyadenosine. Biochem. Biophys. Res. Commun. 1997;238:100
  29. Niitsu N, Honma Y. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia. Leuk. Lymph. 1999;34:261
  30. Niitsu N, Umeda M, Honma Y. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs. Leuk. Res. 2000;24:1
  31. Ehslen H, Brancho DM, Daris RJ. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 2000;19:1301

PII: S0145-2126(01)00026-1

Leukemia Research
Volume 25, Issue 9 , Pages 813-820 , 1 September 2001

Article Tools

* Image Usage & Resolution